Skip to main content
Journal cover image

INDUCTION OF IMMUNOLOGIC AND CLINICAL RESPONSES WITH EGFRVIII-TARGETED VACCINE (CDX-110) WITH CYCLES OF TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED EGFRVIII-POSITIVE GBM

Publication ,  Journal Article
Archer, GE; Heimberger, AB; Bigner, DD; Davis, T; Friedman, HS; Keler, T; McLendon, RE; Mitchell, DA; Reardon, D; Sawaya, R; Vredenberg, J ...
Published in: NEURO-ONCOLOGY
April 1, 2009

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

April 1, 2009

Volume

11

Issue

2

Start / End Page

224 / 224

Location

Tokyo, JAPAN

Publisher

DUKE UNIV PRESS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Archer, G. E., Heimberger, A. B., Bigner, D. D., Davis, T., Friedman, H. S., Keler, T., … Sampson, J. H. (2009). INDUCTION OF IMMUNOLOGIC AND CLINICAL RESPONSES WITH EGFRVIII-TARGETED VACCINE (CDX-110) WITH CYCLES OF TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED EGFRVIII-POSITIVE GBM. NEURO-ONCOLOGY, 11(2), 224–224.
Archer, Gary E., Amy B. Heimberger, Darell D. Bigner, Tom Davis, Henry S. Friedman, Tibor Keler, Roger E. McLendon, et al. “INDUCTION OF IMMUNOLOGIC AND CLINICAL RESPONSES WITH EGFRVIII-TARGETED VACCINE (CDX-110) WITH CYCLES OF TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED EGFRVIII-POSITIVE GBM.” NEURO-ONCOLOGY 11, no. 2 (April 1, 2009): 224–224.
Archer GE, Heimberger AB, Bigner DD, Davis T, Friedman HS, Keler T, et al. INDUCTION OF IMMUNOLOGIC AND CLINICAL RESPONSES WITH EGFRVIII-TARGETED VACCINE (CDX-110) WITH CYCLES OF TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED EGFRVIII-POSITIVE GBM. NEURO-ONCOLOGY. 2009 Apr 1;11(2):224–224.
Archer GE, Heimberger AB, Bigner DD, Davis T, Friedman HS, Keler T, McLendon RE, Mitchell DA, Reardon D, Sawaya R, Vredenberg J, Sampson JH. INDUCTION OF IMMUNOLOGIC AND CLINICAL RESPONSES WITH EGFRVIII-TARGETED VACCINE (CDX-110) WITH CYCLES OF TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED EGFRVIII-POSITIVE GBM. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2009 Apr 1;11(2):224–224.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

April 1, 2009

Volume

11

Issue

2

Start / End Page

224 / 224

Location

Tokyo, JAPAN

Publisher

DUKE UNIV PRESS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences